Morphogen-IX's Seed VC Round

Morphogen-IX raised a round of funding on January 19, 2016.

Morphogen-IX is advancing a new treatment for pulmonary arterial hypertension (PAH) that directly targets the major pathway implicated in human genetic studies.…

Articles about Morphogen-IX's Seed VC Round: